BIO Asks Congress to Extend Critical Bioenergy Tax Credits During Lame-Duck

Oct 18 2016
BIO today sent a letter to Congressional Leadership, the Senate Finance Committee Chairs, and the House Ways and Means Committee Chairs calling for the extension of renewable energy tax credits slated to expire at the end of 2016. In its letter, BIO urges Congress to advance a multi-year extension of the Second Generation Biofuel Producer Tax Credit, the Special Depreciation Allowance for Second Generation Biofuel Plant Property, the Biodiesel and Renewable Diesel Fuels Credit, and the Alternative Fuel Vehicle Refueling Property.

BIO Names Dana O’Brien Executive Vice President for Food & Agriculture Section

Oct 13 2016
BIO announced today that Dana O’Brien has been named BIO’s Executive Vice President for its Food & Agriculture Section.

New BIO Report Dispels the Myth of the Blend Wall and High RIN Prices

Oct 4 2016
Data recently released by EPA on compliance with the Renewable Fuel Standard between 2010 and 2013 (the latest year for which compliance is complete) challenges the widely accepted assumption that the blend wall – the point at which ethanol blending in gasoline exceeds 10 percent – caused the 2013 spike in Renewable Identification Number (RIN) spot market prices.

BIO Statement on Biosimilar User Fee Act Goals Letter

Sep 26 2016
Washington, D.C. (September 16, 2016) – Biotechnology Innovation Organization (BIO) Senior Vice President for Science Policy Kay Holcombe released the following statement today regarding the Biosimilar User Fee Act (BsUFA) II goals letter:

BIO Applauds Senate Passage of Advancing Hope Act

Sep 23 2016
Washington, D.C. (September 23, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today regarding Senate passage of the Advancing Hope Act of 2016:

BIO Statement Regarding the UN High Level Panel on Access to Medicines Report

Sep 14 2016
Sadly the United Nations High Level Panel ignored the real issues that impact or delay delivery of innovative treatments and cures throughout the developing world, while focusing on policy recommendations in the one area – intellectual property – that would actually undermine ongoing research and development by hundreds of companies, universities and researchers.  

BIO Investor Forum 2016 Programming Announced

Sep 7 2016
BIO announced programming for the 15th annual BIO Investor Forum. Held on October 18-19 at the Westin St. Francis Hotel in San Francisco, the BIO Investor Forum explores global investment trends and opportunities in life sciences. Early and mid-stage private as well as emerging public companies poised for growth in 2017 are the focus of the event.

BIO Releases New Report on Renewable Chemical Biorefinery Commercialization

Sep 7 2016
BIO released the new report “Advancing the Biobased Economy: Renewable Chemical Biorefinery Commercialization, Progress, and Market Opportunities, 2016 and Beyond,” documenting substantial, ongoing growth in the renewable chemical industry and outlining federal and state policies that support the industry.

BIO Launches “Innovation Saves” Ad to Highlight Value of Biopharmaceutical Innovation

Sep 6 2016
BIO launched a new television ad focused on biopharmaceutical innovation and its unique ability to help both save lives and save money.  The new ad, along with its “Innovation Saves” website, is a new chapter in BIO’s Value Campaign, which seeks to highlight the value of biopharmaceutical innovation, the importance of protecting the ecosystem that makes new cures and treatments possible and ensuring that patients have access to these important innovations. 

Life Sciences Community Joins Rep. Charlie Dent to Discuss State of the Industry and Positive Impact on Pennsylvania

Aug 18 2016
Pennsylvania’s concentration of bioscience employment is nine percent greater than national average